Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asclepius Technology Group (ATG) is a medical technology company specializing in advanced radiotherapy solutions for cancer treatment. The company focuses on the development and commercialization of intraoperative radiotherapy (IORT) systems and ultra-high dose rate FLASH radiotherapy technology. Their flagship products aim to provide precise, localized radiation during surgery, reducing treatment times and minimizing damage to healthy tissue. ATG operates primarily out of China and targets a wide range of solid tumors, including breast and gastrointestinal cancers. The company is recognized for its innovation in the FLASH-RT space, which has the potential to revolutionize radiation oncology by delivering therapeutic doses in milliseconds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asclepius Technology Group.